Literature DB >> 31879520

Acute Myocardial Infarction Involving Left Main Artery in a Patient with Antiphospholipid Syndrome.

Wei-Hsiang Wang1, Yen-Chou Chen2, Ming-Hsiung Hsieh2,3.   

Abstract

Entities:  

Year:  2019        PMID： 31879520      PMCID： PMC6859107          DOI： 10.6515/ACS.201911_35(6).20190829A

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN： 1011-6842            Impact factor:   2.672


× No keyword cloud information.
  10 in total

1.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).

Authors:  S Miyakis; M D Lockshin; T Atsumi; D W Branch; R L Brey; R Cervera; R H W M Derksen; P G DE Groot; T Koike; P L Meroni; G Reber; Y Shoenfeld; A Tincani; P G Vlachoyiannopoulos; S A Krilis
Journal:  J Thromb Haemost       Date:  2006-02       Impact factor: 5.824

Review 2.  Diagnosis and Management of the Antiphospholipid Syndrome.

Authors:  David Garcia; Doruk Erkan
Journal:  N Engl J Med       Date:  2018-05-24       Impact factor: 91.245

3.  The second Euro Heart Survey on acute coronary syndromes: Characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004.

Authors:  Lori Mandelzweig; Alex Battler; Valentina Boyko; Hector Bueno; Nicolas Danchin; Gerasimos Filippatos; Anselm Gitt; David Hasdai; Yonathan Hasin; Jaume Marrugat; Frans Van de Werf; Lars Wallentin; Shlomo Behar
Journal:  Eur Heart J       Date:  2006-08-14       Impact factor: 29.983

4.  Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients.

Authors:  Ricard Cervera; Jean-Charles Piette; Josep Font; Munther A Khamashta; Yehuda Shoenfeld; María Teresa Camps; Soren Jacobsen; Gabriella Lakos; Angela Tincani; Irene Kontopoulou-Griva; Mauro Galeazzi; Pier Luigi Meroni; Ronald H W M Derksen; Philip G de Groot; Erika Gromnica-Ihle; Marta Baleva; Marta Mosca; Stefano Bombardieri; Frédéric Houssiau; Jean-Christophe Gris; Isabelle Quéré; Eric Hachulla; Carlos Vasconcelos; Beate Roch; Antonio Fernández-Nebro; Marie-Claire Boffa; Graham R V Hughes; Miguel Ingelmo
Journal:  Arthritis Rheum       Date:  2002-04

Review 5.  Acute myocardial infarction and antiphospholipid antibody syndrome: a systematic review.

Authors:  Salik Nazir; Niranjan Tachamo; Saroj Lohani; Rittu Hingorani; Dilli R Poudel; Anthony Donato
Journal:  Coron Artery Dis       Date:  2017-06       Impact factor: 1.439

6.  Right Ventricle Mass Induced Coronary Artery Steal Phenomenon: A Rare Clinical Manifestation on One Leiomyosarcoma Patient.

Authors:  Weng-Chio Tam; Ho-Shun Cheng; Cheng-Chih Chung; Ming-Hsiung Hsieh
Journal:  Acta Cardiol Sin       Date:  2015-09       Impact factor: 2.672

Review 7.  A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies.

Authors:  Guillermo Ruiz-Irastorza; Beverley J Hunt; Munther A Khamashta
Journal:  Arthritis Rheum       Date:  2007-12-15

8.  Changing Practice Pattern of Acute Coronary Syndromes in Taiwan from 2008 to 2015.

Authors:  Yi-Heng Li; Yu-Wei Chiu; Jun-Jack Cheng; I-Chang Hsieh; Ping-Han Lo; Meng-Huan Lei; Kwo-Chang Ueng; Fu-Tien Chiang; Shih-Hsien Sung; Jen-Yuan Kuo; Ching-Pei Chen; Wen-Ter Lai; Wen-Lieng Lee; Jyh-Hong Chen
Journal:  Acta Cardiol Sin       Date:  2019-01       Impact factor: 2.672

9.  In-Hospital Implementation of Evidence-Based Medications is Associated with Improved Survival in Diabetic Patients with Acute Coronary Syndrome - Data from TSOC ACS-DM Registry.

Authors:  Kuan-Chun Chen; Wei-Hsian Yin; Chih-Cheng Wu; Shih-Hung Chan; Yen-Wen Wu; Kuo Yang Wang; Kuan-Cheng Chang; Juey-Jen Hwang; Wen-Chol Voon; I-Chang Hsieh; Jun-Ted Chong; Wei-Shiang Lin; Chih-Neng Hsu; Kwo-Chang Ueng; Chih-Ping Hsia; Ju-Chi Liu; Jong-Shiuan Yeh; Guang-Yuan Mar; Jhih-Yuan Shih; Jen-Yuan Kuo; Hsuan-Ming Tsao; Wei-Kung Tseng; Cheng-Hsu Yang; Chao-Chien Chang; Chern-En Chiang; Meng-Heng Lei; Jeng-Feng Lin; Kou-Gi Shyu
Journal:  Acta Cardiol Sin       Date:  2018-05       Impact factor: 2.672

10.  Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial.

Authors:  Hannah Cohen; Beverley J Hunt; Maria Efthymiou; Deepa R J Arachchillage; Ian J Mackie; Simon Clawson; Yvonne Sylvestre; Samuel J Machin; Maria L Bertolaccini; Maria Ruiz-Castellano; Nicola Muirhead; Caroline J Doré; Munther Khamashta; David A Isenberg
Journal:  Lancet Haematol       Date:  2016-09       Impact factor: 18.959
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.